Time-dependent expression of cytochrome p450 epoxygenases during human prenatal development

References

• Stoilov I. Cytochrome P450s: coupling development and environment. Trends Genet 2001; 17:629 - 32; http://dx.doi.org/10.1016/S0168-9525(01)02444-1; PMID: 11672862
   PubMed Web of Science ®Google Scholar
• Shen AL, O’Leary KA, Kasper CB. Association of multiple developmental defects and embryonic lethality with loss of microsomal NADPH-cytochrome P450 oxidoreductase. J Biol Chem 2002; 277:6536 - 41; http://dx.doi.org/10.1074/jbc.M111408200; PMID: 11742006
   PubMed Web of Science ®Google Scholar
• Koukouritaki SB, Manro JR, Marsh SA, Stevens JC, Rettie AE, McCarver DG, Hines RN. Developmental expression of human hepatic CYP2C9 and CYP2C19. J Pharmacol Exp Ther 2004; 308:965 - 74; http://dx.doi.org/10.1124/jpet.103.060137; PMID: 14634042
   PubMed Web of Science ®Google Scholar
• Lee CA, Neul D, Clouser-Roche A, Dalvie D, Wester MR, Jiang Y, Jones JP 3rd, Freiwald S, Zientek M, Totah RA. Identification of novel substrates for human cytochrome P450 2J2. Drug Metab Dispos 2010; 38:347 - 56; http://dx.doi.org/10.1124/dmd.109.030270; PMID: 19923256
   PubMed Web of Science ®Google Scholar
• Wolpert L. Positional information and the spatial pattern of cellular differentiation. J Theor Biol 1969; 25:1 - 47; http://dx.doi.org/10.1016/S0022-5193(69)80016-0; PMID: 4390734
   PubMed Web of Science ®Google Scholar
• Enayetallah AE, French RA, Thibodeau MS, Grant DF. Distribution of soluble epoxide hydrolase and of cytochrome P450 2C8, 2C9, and 2J2 in human tissues. J Histochem Cytochem 2004; 52:447 - 54; http://dx.doi.org/10.1177/002215540405200403; PMID: 15033996
   PubMed Web of Science ®Google Scholar
• Bièche I, Narjoz C, Asselah T, Vacher S, Marcellin P, Lidereau R, Beaune P, de Waziers I. Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet Genomics 2007; 17:731 - 42; http://dx.doi.org/10.1097/FPC.0b013e32810f2e58; PMID: 17700362
   PubMed Web of Science ®Google Scholar
• Enayetallah AE, French RA, Grant DF. Distribution of soluble epoxide hydrolase, cytochrome P450 2C8, 2C9 and 2J2 in human malignant neoplasms. J Mol Histol 2006; 37:133 - 41; http://dx.doi.org/10.1007/s10735-006-9050-9; PMID: 16957870
   PubMed Web of Science ®Google Scholar
• Jiang JG, Ning YG, Chen C, Ma D, Liu ZJ, Yang S, Zhou J, Xiao X, Zhang XA, Edin ML, et al. Cytochrome p450 epoxygenase promotes human cancer metastasis. Cancer Res 2007; 67:6665 - 74; http://dx.doi.org/10.1158/0008-5472.CAN-06-3643; PMID: 17638876
   PubMed Web of Science ®Google Scholar
• Gaedigk A, Baker DW, Totah RA, Gaedigk R, Pearce RE, Vyhlidal CA, Zeldin DC, Leeder JS. Variability of CYP2J2 expression in human fetal tissues. J Pharmacol Exp Ther 2006; 319:523 - 32; http://dx.doi.org/10.1124/jpet.106.109215; PMID: 16868033
   PubMed Web of Science ®Google Scholar
• Shen GF, Jiang JG, Fu XN, Wang DW. Promotive effects of epoxyeicosatrienoic acids (EETs) on the proliferation of tumour cells. Ai Zheng 2008; 27:390 - 5
   Google Scholar
• Haggarty P. Placental regulation of fatty acid delivery and its effect on fetal growth--a review. Placenta 2002; 23:Suppl A S28 - 38; http://dx.doi.org/10.1053/plac.2002.0791; PMID: 11978057
   PubMedGoogle Scholar
• Innis SM. Essential fatty acid transfer and fetal development. Placenta 2005; 26:Suppl A S70 - 5; http://dx.doi.org/10.1016/j.placenta.2005.01.005; PMID: 15837071
   PubMed Web of Science ®Google Scholar
• Capdevila JH, Falck JR, Harris RC. Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase. J Lipid Res 2000; 41:163 - 81; PMID: 10681399
   PubMed Web of Science ®Google Scholar
• Montgomery RK, Mulberg AE, Grand RJ. Development of the human gastrointestinal tract: twenty years of progress. Gastroenterology 1999; 116:702 - 31; http://dx.doi.org/10.1016/S0016-5085(99)70193-9; PMID: 10029630
   PubMed Web of Science ®Google Scholar
• Zeldin DC. Epoxygenase pathways of arachidonic acid metabolism. J Biol Chem 2001; 276:36059 - 62; http://dx.doi.org/10.1074/jbc.R100030200; PMID: 11451964
   PubMed Web of Science ®Google Scholar
• Aliaga JC, Deschênes C, Beaulieu JF, Calvo EL, Rivard N. Requirement of the MAP kinase cascade for cell cycle progression and differentiation of human intestinal cells. Am J Physiol 1999; 277:G631 - 41; PMID: 10484389
   PubMed Web of Science ®Google Scholar
• Laprise P, Chailler P, Houde M, Beaulieu JF, Boucher MJ, Rivard N. Phosphatidylinositol 3-kinase controls human intestinal epithelial cell differentiation by promoting adherens junction assembly and p38 MAPK activation. J Biol Chem 2002; 277:8226 - 34; http://dx.doi.org/10.1074/jbc.M110235200; PMID: 11756422
   PubMed Web of Science ®Google Scholar
• Zeldin DC, Foley J, Goldsworthy SM, Cook ME, Boyle JE, Ma J, Moomaw CR, Tomer KB, Steenbergen C, Wu S. CYP2J subfamily cytochrome P450s in the gastrointestinal tract: expression, localization, and potential functional significance. Mol Pharmacol 1997; 51:931 - 43; PMID: 9187259
   PubMed Web of Science ®Google Scholar
• Treluyer JM, Gueret G, Cheron G, Sonnier M, Cresteil T. Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: in-vivo/in-vitro correlation and inducibility. Pharmacogenetics 1997; 7:441 - 52; http://dx.doi.org/10.1097/00008571-199712000-00002; PMID: 9429229
   PubMedGoogle Scholar
• Arnould C, Lelièvre-Pégorier M, Ronco P, Lelongt B. MMP9 limits apoptosis and stimulates branching morphogenesis during kidney development. J Am Soc Nephrol 2009; 20:2171 - 80; http://dx.doi.org/10.1681/ASN.2009030312; PMID: 19713309
   PubMed Web of Science ®Google Scholar
• Ma J, Qu W, Scarborough PE, Tomer KB, Moomaw CR, Maronpot R, Davis LS, Breyer MD, Zeldin DC. Molecular cloning, enzymatic characterization, developmental expression, and cellular localization of a mouse cytochrome P450 highly expressed in kidney. J Biol Chem 1999; 274:17777 - 88; http://dx.doi.org/10.1074/jbc.274.25.17777; PMID: 10364221
   PubMed Web of Science ®Google Scholar
• Gillet JP, Gottesman MM. Mechanisms of multidrug resistance in cancer. In: Zhou J, editor. Multidrug resistance in cancer (Methods in molecular biology. Vol. 596). New York: Humana Press; c2010. p.47-76.
   Google Scholar
• Jiang JG, Chen CL, Card JW, Yang S, Chen JX, Fu XN, Ning YG, Xiao X, Zeldin DC, Wang DW. Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors. Cancer Res 2005; 65:4707 - 15; http://dx.doi.org/10.1158/0008-5472.CAN-04-4173; PMID: 15930289
   PubMed Web of Science ®Google Scholar
• Scripture CD, Sparreboom A, Figg WD. Modulation of cytochrome P450 activity: implications for cancer therapy. Lancet Oncol 2005; 6:780 - 9; http://dx.doi.org/10.1016/S1470-2045(05)70388-0; PMID: 16198984
   PubMed Web of Science ®Google Scholar
• Makwana O, Ahles L, Lencinas A, Selmin OI, Runyan RB. Low-dose trichloroethylene alters cytochrome P450-2C subfamily expression in the developing chick heart. Cardiovasc Toxicol 2013; 13:77 - 84; http://dx.doi.org/10.1007/s12012-012-9180-0; PMID: 22855351
   PubMed Web of Science ®Google Scholar